Cargando…

Acute pediatric hyperammonemia: current diagnosis and management strategies

Acute hyperammonemia may induce a neurologic impairment leading to an acute life-threatening condition. Coma duration, ammonia peak level, and hyperammonemia duration are the main risk factors of hyperammonemia-related neurologic deficits and death. In children, hyperammonemia is mainly caused by se...

Descripción completa

Detalles Bibliográficos
Autores principales: Savy, Nadia, Brossier, David, Brunel-Guitton, Catherine, Ducharme-Crevier, Laurence, Du Pont-Thibodeau, Geneviève, Jouvet, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140721/
https://www.ncbi.nlm.nih.gov/pubmed/30254497
http://dx.doi.org/10.2147/HMER.S140711
_version_ 1783355615808061440
author Savy, Nadia
Brossier, David
Brunel-Guitton, Catherine
Ducharme-Crevier, Laurence
Du Pont-Thibodeau, Geneviève
Jouvet, Philippe
author_facet Savy, Nadia
Brossier, David
Brunel-Guitton, Catherine
Ducharme-Crevier, Laurence
Du Pont-Thibodeau, Geneviève
Jouvet, Philippe
author_sort Savy, Nadia
collection PubMed
description Acute hyperammonemia may induce a neurologic impairment leading to an acute life-threatening condition. Coma duration, ammonia peak level, and hyperammonemia duration are the main risk factors of hyperammonemia-related neurologic deficits and death. In children, hyperammonemia is mainly caused by severe liver failure and inborn errors of metabolism. In an acute setting, obtaining reliable plasma ammonia levels can be challenging because of the preanalytical difficulties that need to be addressed carefully. The management of hyperammonemia includes 1) identification of precipitating factors and cerebral edema presence, 2) a decrease in ammonia production by reducing protein intake and reversing catabolism, and 3) ammonia removal with pharmacologic treatment and, in the most severe cases, with extracorporeal therapies. In case of severe coma, transcranial Doppler ultrasound could be the method of choice to noninvasively monitor cerebral blood flow and titrate therapies.
format Online
Article
Text
id pubmed-6140721
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-61407212018-09-25 Acute pediatric hyperammonemia: current diagnosis and management strategies Savy, Nadia Brossier, David Brunel-Guitton, Catherine Ducharme-Crevier, Laurence Du Pont-Thibodeau, Geneviève Jouvet, Philippe Hepat Med Review Acute hyperammonemia may induce a neurologic impairment leading to an acute life-threatening condition. Coma duration, ammonia peak level, and hyperammonemia duration are the main risk factors of hyperammonemia-related neurologic deficits and death. In children, hyperammonemia is mainly caused by severe liver failure and inborn errors of metabolism. In an acute setting, obtaining reliable plasma ammonia levels can be challenging because of the preanalytical difficulties that need to be addressed carefully. The management of hyperammonemia includes 1) identification of precipitating factors and cerebral edema presence, 2) a decrease in ammonia production by reducing protein intake and reversing catabolism, and 3) ammonia removal with pharmacologic treatment and, in the most severe cases, with extracorporeal therapies. In case of severe coma, transcranial Doppler ultrasound could be the method of choice to noninvasively monitor cerebral blood flow and titrate therapies. Dove Medical Press 2018-09-12 /pmc/articles/PMC6140721/ /pubmed/30254497 http://dx.doi.org/10.2147/HMER.S140711 Text en © 2018 Savy et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Savy, Nadia
Brossier, David
Brunel-Guitton, Catherine
Ducharme-Crevier, Laurence
Du Pont-Thibodeau, Geneviève
Jouvet, Philippe
Acute pediatric hyperammonemia: current diagnosis and management strategies
title Acute pediatric hyperammonemia: current diagnosis and management strategies
title_full Acute pediatric hyperammonemia: current diagnosis and management strategies
title_fullStr Acute pediatric hyperammonemia: current diagnosis and management strategies
title_full_unstemmed Acute pediatric hyperammonemia: current diagnosis and management strategies
title_short Acute pediatric hyperammonemia: current diagnosis and management strategies
title_sort acute pediatric hyperammonemia: current diagnosis and management strategies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140721/
https://www.ncbi.nlm.nih.gov/pubmed/30254497
http://dx.doi.org/10.2147/HMER.S140711
work_keys_str_mv AT savynadia acutepediatrichyperammonemiacurrentdiagnosisandmanagementstrategies
AT brossierdavid acutepediatrichyperammonemiacurrentdiagnosisandmanagementstrategies
AT brunelguittoncatherine acutepediatrichyperammonemiacurrentdiagnosisandmanagementstrategies
AT ducharmecrevierlaurence acutepediatrichyperammonemiacurrentdiagnosisandmanagementstrategies
AT dupontthibodeaugenevieve acutepediatrichyperammonemiacurrentdiagnosisandmanagementstrategies
AT jouvetphilippe acutepediatrichyperammonemiacurrentdiagnosisandmanagementstrategies